{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T07:28:59Z","timestamp":1771658939859,"version":"3.50.1"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>The long-term effects of children hospitalized with multisystem inflammatory syndrome in children (MIS-C) or acute COVID-19 are not well known. Our objective was to determine long-term outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Children hospitalized with MIS-C or COVID-19 at 3 US hospitals from March 2020, through February 2021 were followed to assess health through 2 years post-hospitalization using medical records and patient surveys.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Medical record abstraction was performed for 183 patients hospitalized with MIS-C, 53 of whom participated in surveys, and 97 patients hospitalized with COVID-19, 35 of whom participated in surveys. Patients with MIS-C were younger (median, 9 vs. 14 years of age for COVID-19 patients; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.004), more frequently male (62% vs. 39%; <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001) and had more cardiac (14% vs. 2%; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.001) and neurologic sequelae (8% vs. 1%; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.023). Children with COVID-19 more often had other comorbidities (59% vs. 19%; <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001). Full mental recovery at the time of survey 2 (median, 16 months post-hospitalization for patients with MIS-C and 20 months for patients with COVID-19) was 85% and 88%, respectively; full physical recovery was 87% and 81%, respectively; and nearly all had resumption of normal activities. Patients with MIS-C reported more frequent headache at 1 month (45% vs. 20%; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.037). Patients with COVID-19 were more likely to report cough at 1 month (37% vs. 17%; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.045). Fatigue persisted &gt;1 year in 15%\u201320% of patients in both groups.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Approximately 20% of children with MIS-C and COVID-19 continued to have symptoms including fatigue and headache &gt;1 year after hospital discharge. The duration of these findings emphasizes the importance of providers following patients until sequelae have resolved.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000004477","type":"journal-article","created":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T19:12:33Z","timestamp":1724181153000},"page":"1074-1082","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Long-term Health Outcomes After Hospital Discharge Among Children Hospitalized for MIS-C or COVID-19, September 29, 2021, to June 21, 2022"],"prefix":"10.1097","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4106-0953","authenticated-orcid":false,"given":"Shana","family":"Godfred-Cato","sequence":"first","affiliation":[{"name":"COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amber","family":"Kunkel","sequence":"additional","affiliation":[{"name":"COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia"},{"name":"Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph Y.","family":"Abrams","sequence":"additional","affiliation":[{"name":"COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ami B.","family":"Shah","sequence":"additional","affiliation":[{"name":"COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia"},{"name":"General Dynamics Information Technology, Falls Church, Virginia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Yousaf","sequence":"additional","affiliation":[{"name":"COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa A.","family":"Hammett","sequence":"additional","affiliation":[{"name":"COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong-Ha","family":"Choi","sequence":"additional","affiliation":[{"name":"COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia"},{"name":"Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia and Children\u2019s Healthcare of Atlanta, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria A.","family":"Perez","sequence":"additional","affiliation":[{"name":"COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia"},{"name":"Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia and Children\u2019s Healthcare of Atlanta, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Mien","family":"Hsiao","sequence":"additional","affiliation":[{"name":"COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia"},{"name":"Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia and Children\u2019s Healthcare of Atlanta, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina A.","family":"Rostad","sequence":"additional","affiliation":[{"name":"COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia"},{"name":"Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia and Children\u2019s Healthcare of Atlanta, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico R.","family":"Laham","sequence":"additional","affiliation":[{"name":"COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia"},{"name":"Division of Pediatric Infectious Diseases, Orlando Health Arnold Palmer Hospital for Children, Orlando, Florida."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol M.","family":"Kao","sequence":"additional","affiliation":[{"name":"COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia"},{"name":"Division of Pediatric Infectious Diseases, Orlando Health Arnold Palmer Hospital for Children, Orlando, Florida."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Hunstad","sequence":"additional","affiliation":[{"name":"COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia"},{"name":"Division of Pediatric Infectious Diseases, Orlando Health Arnold Palmer Hospital for Children, Orlando, Florida."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew E.","family":"Oster","sequence":"additional","affiliation":[{"name":"COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela P.","family":"Campbell","sequence":"additional","affiliation":[{"name":"COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ermias D.","family":"Belay","sequence":"additional","affiliation":[{"name":"COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,8,15]]},"reference":[{"key":"R1-20250614","article-title":"COVID data tracker: nationwide commercial lab pediatric antibody seroprevalence."},{"key":"R2-20250614","doi-asserted-by":"crossref","first-page":"713","DOI":"10.15585\/mmwr.mm7121e1","article-title":"Post\u2013COVID conditions among adult COVID-19 survivors aged 18\u201364 and \u226565 years \u2014 United States, March 2020\u2013November 2021.","volume":"71","author":"Bull-Otterson","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R3-20250614","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1093\/cid\/ciad045","article-title":"Severe fatigue and persistent symptoms at three months following SARS-CoV-2 infections during the pre-delta, delta, and omicron time periods: a multicenter prospective cohort study.","volume":"76","author":"Gottlieb","year":"2023","journal-title":"Clin Infect Dis"},{"key":"R4-20250614","doi-asserted-by":"crossref","first-page":"59","DOI":"10.15585\/mmwr.mm7102e2","article-title":"Risk for newly diagnosed diabetes >30 days after SARS-CoV-2 infection among persons aged <18 years \u2014 United States, March 1, 2020\u2013June 28, 2021.","volume":"71","author":"Barrett","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R5-20250614","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1001\/jamapediatrics.2022.2800","article-title":"Clinical features and burden of postacute sequelae of SARS-CoV-2 infection in children and adolescents.","volume":"176","author":"Rao","year":"2022","journal-title":"JAMA Pediatr"},{"key":"R6-20250614","doi-asserted-by":"crossref","first-page":"o143","DOI":"10.1136\/bmj.o143","article-title":"Long covid in children and adolescents.","volume":"376","author":"Zimmermann","year":"2022","journal-title":"BMJ"},{"key":"R7-20250614","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/MOP.0000000000001221","article-title":"Diagnosis and management of post-COVID (long COVID) in children: a moving target.","volume":"35","author":"Morello","year":"2023","journal-title":"Curr Opin Pediatr"},{"key":"R9-20250614","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1136\/archdischild-2021-323624","article-title":"Long COVID (post-COVID-19 condition) in children: a modified Delphi process.","volume":"107","author":"Stephenson","year":"2022","journal-title":"Arch Dis Child"},{"key":"R10-20250614","article-title":"Post COVID-19 condition (long COVID)."},{"key":"R11-20250614","article-title":"Long COVID definition."},{"key":"R12-20250614","article-title":"Long COVID."},{"key":"R13-20250614","doi-asserted-by":"crossref","first-page":"e0282538","DOI":"10.1371\/journal.pone.0282538","article-title":"Prevalence of mental health problems among children with long COVID: a systematic review and meta-analysis.","volume":"18","author":"Mat Hassan","year":"2023","journal-title":"PLoS One"},{"key":"R14-20250614","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","article-title":"Long COVID: major findings, mechanisms and recommendations.","volume":"21","author":"Davis","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"R15-20250614","doi-asserted-by":"crossref","first-page":"e2147053","DOI":"10.1001\/jamanetworkopen.2021.47053","article-title":"Prevalence of select new symptoms and conditions among persons aged younger than 20 years and 20 years or older at 31 to 150 days after testing positive or negative for SARS-CoV-2.","volume":"5","author":"Hernandez-Romieu","year":"2022","journal-title":"JAMA Netw Open"},{"key":"R16-20250614","doi-asserted-by":"crossref","first-page":"101961","DOI":"10.1016\/j.eclinm.2023.101961","article-title":"Risk factors for post-COVID-19 condition (long COVID) in children: a prospective cohort study.","volume":"59","author":"Morello","year":"2023","journal-title":"EClinicalMedicine"},{"key":"R17-20250614","doi-asserted-by":"crossref","first-page":"e741","DOI":"10.1093\/cid\/ciab936","article-title":"Multisystem inflammatory syndrome in adults after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and coronavirus disease 2019 (COVID-19) vaccination.","volume":"75","author":"Belay","year":"2022","journal-title":"Clin Infect Dis"},{"key":"R18-20250614","article-title":"Health Department-reported cases of multisystem inflammatory syndrome in children (MIS-C) in the United States."},{"key":"R19-20250614","doi-asserted-by":"crossref","first-page":"S303","DOI":"10.1093\/cid\/ciac471","article-title":"Multisystem inflammatory syndrome in children during severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) delta and omicron variant circulation-United States, July 2021-January 2022.","volume":"75","author":"Miller","year":"2022","journal-title":"Clin Infect Dis"},{"key":"R20-20250614","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1093\/cid\/ciab1007","article-title":"Multisystem inflammatory syndrome in children-United States, February 2020-July 2021.","volume":"75","author":"Miller","year":"2021","journal-title":"Clin Infect Dis"},{"key":"R21-20250614","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1080\/07853890.2022.2076901","article-title":"Pathophysiology and mechanism of long COVID: a comprehensive review.","volume":"54","author":"Castanares-Zapatero","year":"2022","journal-title":"Ann Med"},{"key":"R22-20250614","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.cell.2020.09.016","article-title":"The Immunology of multisystem inflammatory syndrome in children with COVID-19.","volume":"183","author":"Consiglio","year":"2020","journal-title":"Cell"},{"key":"R23-20250614","doi-asserted-by":"crossref","first-page":"e2021050973","DOI":"10.1542\/peds.2021-050973","article-title":"Six month follow-up of patients with multi-system inflammatory syndrome in children.","volume":"148","author":"Capone","year":"2021","journal-title":"Pediatrics"},{"key":"R24-20250614","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00246-022-02972-3","article-title":"Longitudinal assessment of cardiac function following multisystem inflammatory syndrome in children associated with COVID-19.","volume":"44","author":"Das","year":"2023","journal-title":"Pediatr Cardiol"},{"key":"R25-20250614","doi-asserted-by":"crossref","first-page":"e2021051155","DOI":"10.1542\/peds.2021-051155","article-title":"Longitudinal outcomes for multisystem inflammatory syndrome in children.","volume":"148","author":"Farooqi","year":"2021","journal-title":"Pediatrics"},{"key":"R26-20250614","doi-asserted-by":"crossref","first-page":"820229","DOI":"10.3389\/fped.2022.820229","article-title":"Longitudinal outcomes and monitoring of patients with multisystem inflammatory syndrome in children.","volume":"10","author":"Fremed","year":"2022","journal-title":"Front Pediatr"},{"key":"R27-20250614","doi-asserted-by":"crossref","first-page":"e023251","DOI":"10.1161\/JAHA.121.023251","article-title":"Longitudinal assessment of cardiac outcomes of multisystem inflammatory syndrome in children associated with COVID-19 infections.","volume":"11","author":"Matsubara","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"R28-20250614","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S2352-4642(21)00138-3","article-title":"6-month multidisciplinary follow-up and outcomes of patients with paediatric inflammatory multisystem syndrome (PIMS-TS) at a UK tertiary paediatric hospital: a retrospective cohort study.","volume":"5","author":"Penner","year":"2021","journal-title":"Lancet Child Adolesc Health"},{"key":"R29-20250614","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/apa.16191","article-title":"Population-based study of multisystem inflammatory syndrome associated with COVID-19 found that 36% of children had persistent symptoms.","volume":"111","author":"Kahn","year":"2022","journal-title":"Acta Paediatr"},{"key":"R30-20250614","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1001\/jama.2021.2091","article-title":"Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe acute COVID-19.","volume":"325","author":"Feldstein","year":"2021","journal-title":"JAMA"},{"key":"R31-20250614","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.pediatrneurol.2021.12.010","article-title":"Prevalence and risk factors of neurologic manifestations in hospitalized children diagnosed with acute SARS-CoV-2 or MIS-C.","volume":"128","author":"Fink","year":"2022","journal-title":"Pediatr Neurol"},{"key":"R32-20250614","doi-asserted-by":"crossref","first-page":"e2022057798","DOI":"10.1542\/peds.2022-057798","article-title":"Health impairments in children and adolescents after hospitalization for acute COVID-19 or MIS-C.","volume":"150","author":"Maddux","year":"2022","journal-title":"Pediatrics"},{"key":"R33-20250614","doi-asserted-by":"crossref","first-page":"1260372","DOI":"10.3389\/fped.2023.1260372","article-title":"Risk factors for health impairments in children after hospitalization for acute COVID-19 or MIS-C.","volume":"11","author":"Maddux","year":"2023","journal-title":"Front Pediatr"},{"key":"R34-20250614","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/INF.0000000000003449","article-title":"Distinguishing multisystem inflammatory syndrome in children from COVID-19, kawasaki disease and toxic shock syndrome.","volume":"41","author":"Godfred-Cato","year":"2022","journal-title":"Pediatr Infect Dis J"},{"key":"R35-20250614","article-title":"CDC 2020 multisystem inflammatory syndrome in children (MIS-C) surveillance case definition."},{"key":"R36-20250614","article-title":"Coronavirus disease 2019 (COVID-19) 2021 case definition."},{"key":"R37-20250614","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/INF.0000000000003803","article-title":"COVID-19 vaccine reactogenicity and vaccine attitudes among children and parents\/guardians after multisystem inflammatory syndrome in children or COVID-19 hospitalization: September 2021-May 2022.","volume":"42","author":"Yousaf","year":"2023","journal-title":"Pediatr Infect Dis J"},{"key":"R38-20250614","article-title":"Multisystem inflammatory syndrome in children (MIS-C) interim guidance."},{"key":"R39-20250614","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1002\/art.42062","article-title":"American College of Rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with SARS-CoV-2 and hyperinflammation in pediatric COVID-19: version 3.","volume":"74","author":"Henderson","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"R40-20250614","doi-asserted-by":"crossref","first-page":"622240","DOI":"10.3389\/fped.2021.622240","article-title":"COVID-19 in children: respiratory involvement and some differences with the adults.","volume":"9","author":"Jurado Hern\u00e1ndez","year":"2021","journal-title":"Front Pediatr"},{"key":"R41-20250614","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1136\/archdischild-2020-321220","article-title":"New-onset type 1 diabetes in Finnish children during the COVID-19 pandemic.","volume":"107","author":"Salmi","year":"2022","journal-title":"Arch Dis Child"},{"key":"R42-20250614","article-title":"COVID-19 interim guidance: return to sports and physical activity."},{"key":"R43-20250614","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1136\/archdischild-2022-324656","article-title":"Post-COVID-19 condition at 6 months and COVID-19 vaccination in non-hospitalised children and young people.","volume":"108","author":"Pinto Pereira","year":"2023","journal-title":"Arch Dis Child"},{"key":"R44-20250614","doi-asserted-by":"crossref","first-page":"52","DOI":"10.15585\/mmwr.mm7102e1","article-title":"Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA vaccination against multisystem inflammatory syndrome in children among persons aged 12-18 years - United States, July-December 2021.","volume":"71","author":"Zambrano","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004477","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T23:04:53Z","timestamp":1749942293000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,15]]},"references-count":43,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000004477","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,15]]}}}